Skip to main content

Month: September 2021

AIM ImmunoTech Announces Positive Progress on Requested FDA Meeting for Proposed Ampligen Clinical Trial in Post-COVID-19 Cognitive Dysfunction

OCALA, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today announced positive progress with the company’s meeting request to the U.S. Food and Drug Administration (FDA) concerning a Phase 2 clinical study of Ampligen as an infusion therapy for Post-COVID-19 Cognitive Dysfunction (PCCD). The meeting request has been deemed sufficient for transfer to the FDA’s Division of Neurology by the FDA’s Covid Scientific Technical Triage Team. “We are pleased with this next step — the referral to the FDA’s Division of Neurology — as our focus is on the brain-related symptoms of Long COVID,” said AIM CEO Thomas K. Equels. The planned Phase 2, two-arm, randomized, double blind, placebo controlled, multicenter study is designed to evaluate the efficacy and safety of Ampligen in patients experiencing PCCD. Eighty...

Continue reading

Plato Gold Initiates a High-Resolution Airborne Magnetic and Radiometric Survey on the Good Hope Niobium Project

TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC; Frankfurt: 4Y7 or WKN: A0M2QX) is pleased to announce it has signed a contract with Prospectair Geosurveys Inc. of Quebec to conduct a high-resolution Magnetic and Radiometric airborne geophysical survey on the Good Hope Niobium Project, located 60 km northwest of Marathon, Ontario. The survey is scheduled to begin at the end of September 2021 and be completed over a period of 1 to 3 days. A Media Snippet accompanying this announcement is available by clicking on the image or link below:Good Hope Niobium Property Location A Media Snippet accompanying this announcement is available by clicking on the image or link below:Geophysical Survey Plan (Prospectair Geosurveys Inc.) The planned airborne survey will better define the potential of the area surrounding...

Continue reading

VectivBio Announces Closing of Comet Therapeutics Acquisition

– Proprietary CoMET platform aims to treat severe rare Inherited Metabolic Diseases – BASEL, Switzerland, Sept. 21, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the closing of its previously announced acquisition of Comet Therapeutics, Inc., a privately held company that has been developing drugs to address previously untreatable Inherited Metabolic Diseases (IMDs). Omar Khwaja, M.D., Ph.D., Chief Medical Officer of VectivBio, will present the CoMET platform at today’s VectivBio R&D Day, 10 a.m. – 12 p.m. EDT, that can be accessed by visiting the “Events & Presentations” section of VectivBio’s website. The CoMET small molecule platform aims to treat...

Continue reading

LGI Homes Opens New Section at Vacek Country Meadows in Richmond, Texas

Homebuilder offers move-in ready homes priced from the $240s in a highly desirable location in Fort Bend CountyThe Blanco plan at Vacek Country Meadows by LGI HomesLGI Homes at Vacek Country Meadows offers new, move-in ready homes and family-friendly amenities in Richmond, Texas. Pricing begins in the $240s.RICHMOND, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) today announced the company’s return to Vacek Country Meadows in Richmond, Texas, where the builder is constructing an additional 168 single-family homes priced from the $240s. Homeowners at Vacek Country Meadows enjoy move-in ready homes equipped with LGI’s CompleteHome™ package and a private neighborhood situated near I-69, TX-99 and the Sam Houston Tollway. “Vacek County Meadows offers a tremendous value to buyers in Fort Bend...

Continue reading

BioCryst to Present at 2021 Cantor Virtual Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the 2021 Cantor Virtual Healthcare Conference on Tuesday, September 28, 2021 at 2:00 p.m. ET. Links to a live audio webcast and replay of this presentation may be accessed in the Investors section of BioCryst’s website at http://www.biocryst.com. About BioCryst Pharmaceuticals BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO® (berotralstat) is approved in the United States, the European Union, Japan, the United Kingdom and the United Arab Emirates. BioCryst has several ongoing development...

Continue reading

Stingray Renews Its Normal Course Issuer Bid

MONTREAL, Sept. 21, 2021 (GLOBE NEWSWIRE) — Stingray Group Inc (TSX: RAY.A; RAY.B) (“Stingray”), a leading music, media and technology company, today announced that the Toronto Stock Exchange (“TSX”) has approved the renewal of its normal course issuer bid (“NCIB”), authorizing Stingray to repurchase up to an aggregate 3,222,901 subordinate voting shares and variable subordinate voting shares (collectively, “Subordinate Shares”), representing approximately 10% of the public float of Subordinate Shares as at September 13, 2021. The net average daily trading volume for the six-month period preceding September 1, 2021 represents 48,521 Subordinate Shares. In accordance with TSX requirements, Stingray is entitled to purchase, on any trading day, up to a total of 12,130 Subordinate Shares representing 25% of this average daily trading...

Continue reading

Following the Successful Launch of Else Kid’s Complete Nutrition Shakes, Else Launches New Flavors

Plant-Powered Complete Nutrition Shakes for Kids Now Available in Banana Chia and Mango Chia Exclusively on elsenutrition.com, Followed by Amazon and Other Key RetailersNew FlavorsBanana & Mango FlavorVANCOUVER, British Columbia, Sept. 21, 2021 (GLOBE NEWSWIRE) — ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company, today announced the launch of two new flavors of its Complete Nutrition Shakes for Kids – Banana Chia and Mango Chia – giving parents even more sustainable, clean label, whole food based options. Made from whole food, clean ingredients, including organic almonds, buckwheat and tapioca, which account for 95 percent of the ingredients, Else Complete Nutrition Shakes for Kids...

Continue reading

Recro Signs Renewable Energy Agreement With Georgia Power

Investment in Renewable Energy Credits Represents Key Component of Company’s Ongoing Environmental Sustainability Program EXTON, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) — Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges in small molecule therapeutic development, today announced the signing of a renewable energy agreement with Georgia Power under which the company will purchase 1.2 million renewable energy credits (RECs) through Georgia Power’s Simple Solar Program. The RECs purchased by Recro under this agreement support the generation of renewable electricity from low- or zero-emission resources, while also reducing the emissions associated with the company’s electricity use. Today’s announcement is being made...

Continue reading

Mosaic Minerals Announces Transaction With IAMGOLD and Gaboury Project Update

Gaboury Project Area Ni ShowingsGaboury Project Area Ni ShowingsMONTRÉAL, Sept. 21, 2021 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or the “Corporation”) is pleased to announce that it has completed a transaction to sell mining claims to IAMGOLD Corporation (TSX : IMG, NYSE: IAG). The transaction consists of IAMGOLD acquiring 100% interest in 4 mining claims formerly part of the Opawica Property (Chibougamau mining camp) for a total aggregate purchase price of $150,000 payable to Mosaic according to the following schedule: $50,000 within 10 business days of the closing, $50,000 on or before the date that is one year following the closing date and $50,000 on or before the date that is 18 months following the closing date. Mosaic will also retain a 0.5% net smelter royalty (“NSR”) on the...

Continue reading

Ketamine One Signs LOI with Veteran Services USA to Open Therapy Center

Ketamine-Assisted Treatment Facility to Be Part of a Medical Complex in Blue Island, Illinois VANCOUVER, British Columbia, Sept. 21, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it has recently signed a non-binding letter of interest (“LOI”) with Veteran Services USA (“VSUSA”) to lease approximately 5,000 square feet of space over an initial term of five years (the “Lease”) in Blue Island, Illinois (the “Blue Island Therapy Center”). Located in the former MetroSouth Medical Center, the Blue Island Therapy Center is being planned to be part of a larger medical complex. Ketamine One will leverage its experience...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.